SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,780,000 | +45.9% | 178,136 | -11.7% | 0.02% | +23.5% |
| Q3 2020 | $1,906,000 | -2.8% | 201,722 | -7.8% | 0.02% | 0.0% |
| Q2 2020 | $1,961,000 | +26.4% | 218,874 | -10.2% | 0.02% | 0.0% |
| Q1 2020 | $1,552,000 | -25.5% | 243,672 | -2.1% | 0.02% | +13.3% |
| Q4 2019 | $2,084,000 | -16.2% | 248,959 | -9.4% | 0.02% | -21.1% |
| Q3 2019 | $2,488,000 | -21.5% | 274,908 | -6.6% | 0.02% | -20.8% |
| Q2 2019 | $3,171,000 | -20.0% | 294,448 | -29.1% | 0.02% | -14.3% |
| Q1 2019 | $3,962,000 | -22.2% | 415,256 | -6.3% | 0.03% | -31.7% |
| Q4 2018 | $5,090,000 | -33.4% | 443,386 | -1.7% | 0.04% | -16.3% |
| Q3 2018 | $7,647,000 | +15.2% | 451,156 | -3.5% | 0.05% | +4.3% |
| Q2 2018 | $6,637,000 | -26.5% | 467,381 | -1.7% | 0.05% | -28.8% |
| Q1 2018 | $9,032,000 | +15.3% | 475,388 | -0.5% | 0.07% | +15.8% |
| Q4 2017 | $7,835,000 | +7.1% | 477,726 | -2.1% | 0.06% | +7.5% |
| Q3 2017 | $7,317,000 | +68.0% | 487,788 | -1.5% | 0.05% | +65.6% |
| Q2 2017 | $4,356,000 | +67.6% | 495,028 | -1.0% | 0.03% | +68.4% |
| Q1 2017 | $2,599,000 | +67.4% | 499,803 | -1.8% | 0.02% | +58.3% |
| Q4 2016 | $1,553,000 | -34.7% | 509,132 | -1.0% | 0.01% | -36.8% |
| Q3 2016 | $2,380,000 | -20.0% | 514,076 | +0.0% | 0.02% | -20.8% |
| Q2 2016 | $2,976,000 | -40.6% | 513,930 | -37.9% | 0.02% | -40.0% |
| Q1 2016 | $5,007,000 | -33.9% | 827,567 | -0.3% | 0.04% | -36.5% |
| Q4 2015 | $7,575,000 | +24.0% | 829,651 | -23.4% | 0.06% | +23.5% |
| Q3 2015 | $6,107,000 | -71.0% | 1,082,787 | -43.1% | 0.05% | -66.2% |
| Q2 2015 | $21,089,000 | -37.9% | 1,901,604 | -12.2% | 0.15% | -38.4% |
| Q1 2015 | $33,978,000 | +20.0% | 2,166,975 | +16.4% | 0.24% | +17.8% |
| Q4 2014 | $28,314,000 | +22.0% | 1,861,558 | -13.5% | 0.21% | +11.2% |
| Q3 2014 | $23,211,000 | -31.6% | 2,152,179 | -3.2% | 0.19% | -25.2% |
| Q2 2014 | $33,936,000 | +42.5% | 2,222,395 | +68.7% | 0.25% | +45.3% |
| Q1 2014 | $23,815,000 | – | 1,317,190 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |